Despite this, a recent systematic review has analyzed the relationship among IGF-1, growth hormone, and obesity, highlighting that a modulation of these hormones could prevent the progression of metabolic syndrome and associated cardiovascular complications [61]. The gene discussed is IGF1; the disease is obesity due to melanocortin 4 receptor deficiency.